IMPACT BIOMEDICAL INC. (IBO) Balance Sheet
As of 2026-06-30 (10-Q), IMPACT BIOMEDICAL INC. (IBO) reported total assets of $16.7M, total liabilities of $2.7M and shareholders' equity of $10.8M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $10000.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IBOIMPACT BIOMEDICAL INC.Follow IBO — free
—
Price chart with a free account
- Market cap
- 30.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 6 Nov, in 13 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|
| Cash and equivalents | 0.0 | 2.0 | 0.0 | 0.0 | |
| Receivables | 0.0 | 0.2 | 0.0 | — | |
| Inventory | — | — | 0.1 | 0.1 | |
| Current assets | 0.3 | 2.4 | 0.4 | 0.3 | |
| Total assets | 44.6 | 20.3 | 17.4 | 16.7 | |
| Current liabilities | 13.1 | 9.8 | 1.2 | 2.0 | |
| Total liabilities | 16.4 | 13.1 | 1.9 | 2.7 | |
| Shareholders' equity | 25.2 | 4.3 | 12.3 | 10.8 |
USD millions · SEC XBRL
IMPACT BIOMEDICAL INC. — questions
- How much cash does IMPACT BIOMEDICAL INC. have?
- $10000 in cash and cash equivalents as of 2026-06-30.
- What are IMPACT BIOMEDICAL INC.'s total assets?
- $16.7M as of 2026-06-30.
- What is IMPACT BIOMEDICAL INC.'s shareholders' equity?
- $10.8M as of 2026-06-30.
Every figure on this page comes from IMPACT BIOMEDICAL INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.